NCT03065218: A trial that was reported late by Medstar Health Research Institute
This trial has reported, although it was 140 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03065218 |
|---|---|
| Title | Evaluation of 99mTc Sestamibi Scans In Patients Who Have Differentiated Thyroid Cancer, Elevated Serum Thyroglobulin Levels, and Negative Diagnostic Imaging Studies |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Oct. 31, 2016 |
| Completion date | Feb. 15, 2021 |
| Required reporting date | Feb. 15, 2022, midnight |
| Actual reporting date | July 5, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 140 |